Lumata
Life Sciences
Lumata is the first and only company providing care coordination and counseling for patients with chronic eye conditions like glaucoma, diabetic retinopathy and macular degeneration. leverages data-science, technology and patient engagement to provide care coordination for patients most at risk of losing their vision.
Why we invested:
Superior Technology
Patients supported by Lumata’s data-driven platform miss an average of 60% fewer clinic appointments. Lumata’s highly-trained clinical staff is empowered with its unique “Intelligent Engagement” framework: data-driven insights from over 500,000 unique patient records, custom technology, and behavioral science tools.
-
"We could not be more pleased to have Boyd Street Ventures as an investor. Their management team and Strategic Advisory Board can be a great source of insight, particularly in the areas of strategy and operations, and they are actively engaged in the honing for success."
Jesse McCool Co-Founder & CEO, Wheeler Bio -
"James has been extremely helpful in making important introductions for us. I appreciate the fact that he’s always asking me about our plans to grow even faster, and it seems that every time I talk to him he has another great idea for a potential new customer."
Nathan Den Herder Founder & CEO, Ardley